SCHEMBL23037414

SCHEMBL23037414

CC(S)CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23037412 1.00
SCHEMBL8076557 0.80
SCHEMBL7128088 0.80
SCHEMBL7903222 0.77
SCHEMBL20315233 0.77
SCHEMBL20315239 0.77
SCHEMBL23882501 0.76 MAPK1 (0.31)
SCHEMBL16154386 0.76
SCHEMBL23882500 0.76 MAPK1 (0.31)
SCHEMBL839514 0.76 MAPK1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12129258-B2 Diaryl macrocyclic compound and pharmaceutical composition, and use thereof PRIMEGENE (BEIJING) CO., LTD (CN) 2024-10-29 US disclosed
EP-3786167-B1 DIARYL MACROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION, AND USE THEREOF PRIMEGENE BEIJING CO LTD (CN) 2024-08-21 EP disclosed
CN-111902417-B Diaryl macrocyclic compound, pharmaceutical composition and application thereof 北京普祺医药科技股份有限公司 2023-07-28 CN disclosed
US-20220162218-A1 DIARYL MACROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION, AND USE THEREOF PRIMEGENE (BEIJING) CO., LTD. (CN) 2022-05-26 US disclosed
EP-3786167-A1 DIARYL MACROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION, AND USE THEREOF Primegene (Beijing) Co., Ltd. (CN) 2021-03-03 EP disclosed
CN-111902417-A Diaryl macrocycle compound, pharmaceutical composition and application thereof 北京普祺医药科技有限公司 2020-11-06 CN disclosed